Prior to founding ABS, Dr. Saller led the biochemical team at what is now AstraZeneca that worked on the discovery of Seroquel®, one of the most successful drugs of all time both in respect to therapeutic efficacy for psychiatric disorders and market value. Dr. Saller is a serial entrepreneur, having founded Saller Rental Properties in the 1980s, which provided the capital for founding ABS in January 1990. He continues to lead ABS operations and direct its strategy. Dr. Saller has also served as the Principal Investigator or has administered more than $5 million in government grants and contracts as a founder of one other bioscience company and as advisor to others.
Linda supervises all Laboratory Operations at ABS. She has worked at ABS for more than 18 years and has overall responsibility for all ABS Laboratories, Biospecimen Operations, and ABS’ Biorepository. She is also accustomed and highly skilled at working with cross-functional teams and changing client specifications and priorities, having worked closely on many large multi-disciplinary projects. All Laboratory, Biorepository, and Biospecimen Operations personnel report to Linda. She is an ISO 9001:2015 Internal Auditor, Six Sigma Green Belt, and trained in Lean, HIPAA regulations, and GLP/GMP.
Cheri is the Vice President of Business Development & Operations at ABS. She has more than 23 years’ experience managing all aspects of Business Operations at ABS. This includes Accounting, Human Resources, Information Technology, Quality Assurance, Logistics, Facilities Infrastructure, and Business Development. Cheri is qualified in ISO 9001:2015 Management and Internal Auditing. She is also a Six Sigma Green Belt, and is trained in Lean, IATA/ICAO regulations, HIPAA regulations, and GLP/GMP.
Before joining ABS, Heidi obtained her Bachelor’s degree from Kutztown University and her Master’s degree from the College of Charleston. After graduation, she joined ABS’ sales team in 2009 as a Project Manager. She continues to provide excellent customer service as Director of Client Services.
Heidi consults with current and prospective clients in the Mid-Atlantic to identify and provide customized solutions that allow clients to get ahead of deadlines and spend more time focusing on their core competencies. Her love of science initially led to a career teaching middle school science before returning to graduate school to pursue a Master of Science in Biotechnology. During her graduate experience, she realized her expertise was best utilized outside of laboratory research. She believes in her clients’ research, and her goal is to provide them a better pathway to success.
Dania joined ABS in 2012 as a Scientific Liaison before growing to take on more responsibility as a Project Manager the same year. She has a degree in Biology from the University of Delaware and extensive sales experience. Her passion for science, ability to build strong relationships, and commitment to helping people find solutions for their needs makes her role at ABS a natural fit.
Sarah joined ABS as a Business Development Associate in 2019. She provides clients from pharmaceutical and biotechnology companies with custom, quality-guaranteed solutions that help streamline their discovery process and accelerate their pipelines. Her passion for science led her to achieve her Doctorate of Philosophy in Biomedical Engineering from Drexel University prior to joining ABS. Her research expertise, problem-solving mindset, and ability to build strong relationships provides the foundation required to develop successful collaborations with clients in the New England territory.
LeAnne joined ABS in 2020 and brings 25 years of biotech industry experience to her clients at ABS. She quickly found her passion for supporting biomedical team’s research efforts by providing tools to remove obstacles that impede success. She has a Bachelor of Science degree in Animal Science and a minor in Biology from The University of Delaware. Her purpose is to continually provide exceptional service and collaborate on creative solutions that allow her Mid-Atlantic clients to focus on important research and discovery.
Growth encompasses adding new skills, capabilities, and continuously evolving to deliver greater value for our clients.
Responsiveness refers to how effectively and promptly we respond to the business requirements of our clients. It means that we quickly respond to client requests in an open and collaborative manner. It means that we anticipate clients’ needs to increase the value of our collaborations.
Excellence demands that we do what we say we are going to do when we say we will do it every time. This is simple. It is also a major challenge. It includes dependability and reliability in its scope. It means developing more efficient processes so that we deliver quickly on our promises and exceed expectations. It means zero tolerance for errors that impact our clients.
Accountability necessitates that we take ownership of what we do and that we are responsible for what we deliver. It enables us to deliver Excellence. It is a commitment to achieving intended outcomes. It means that we are responsible for the quality and reliability of our work.
Transparency requires us to effectively share information without obfuscation. It is an open search for the truth of how we are doing. It means that we have effective systems and workflows for viewing and sharing information with clients and ABS staff so that we can act quickly and effectively.
ABS is ISO 9001:2015 certified for all production activities. We will provide a copy of our certification upon request.
ABS adheres to NCI and ISBER biobanking best practices.
ABS has a very low staff turnover rate. Consequently, we have a consistently high level of experience serving our clients. Although our focus is pre-clinical research, our staff is GMP- and GLP-trained and have earned Six Sigma certification.
ABS has a near-perfect success rate of shipments arriving intact at the proper temperature.
ISO9001:2015 Certified
